Allergy Flashcards
feature of atopic dermatitis
prominent infraorbital skin folds that extend in an arc from the inner canthus beneath and parallel to the lower lid margin.
Dennie-Morgan folds (Dennie lines)
unique feature of atopy and APCs
Presence of allergen-specific IgE on the cell surfaces of Antigen presenting cells
location of mast cells
adjacent to blood vessels and beneath epithelial surfaces that are exposed to the external environment, such as the respiratory tract, gastrointestinal tract, and skin
early-phase response
immediate response after allergen is introduced
characterized by mast cell degranulation and release of preformed mediators, occurring within an immediate time frame of between 1 and 30 min after allergen exposure and resolving within 1-3 hr
late-phase response
can occur within hours of allergen exposure, reaching a maximum at 6-12 hr and resolving by 24 hr
Late- phase responses are characterized in the skin by edema, redness, and induration; in the nose by sustained nasal blockage; and in the lung by airway obstruction and persistent wheezing
third phase/chronic allergic disease
tissue inflammation can persist for days to years.
recurrent exposure to allergens and microbial agents contribute
a single-gene disorder associated with erythroderma, food allergy, and high serum IgE levels
serine protease inhibitor
Netherton disease
fetus capable of producing igE at
11th wk AOG
igE levels peak at
10 years old
presence of IgE specifc for a particular allergen can be documented ]by the measurement of allergen-specific IgE (sIgE) levels in the serum
radioallergosorbent test RAST previously but now automated enzymatic sIgE immunoassays
intradermal test not used for food allergies because of risk of
anaphylaxis
how long should antihistamines be stopped prior to skin test
3-10 days
performed to document the presence and degree of bronchial hyperreactivity in a patient in whom asthma is suspected
Methacholine challenge
isomer of salbutamol developed to reduce adverse effects
levalbuterol
moa of anticholinergic drugs ie ipratropium
antagonize acteylcholine at muscarinic receptors
ETHYLENEDIAMINES
First-generation
Antazoline, pyrilamine, tripelennamine
TYPE II ETHANOLAMINES
First-generation
Carbinoxamine, clemastine, diphenhydramine
TYPE III ALKYLAMINES
First-generation
Brompheniramine, chlorpheniramine, triprolidine
TYPE III ALKYLAMINES
Second-generation
Acrivastine
TYPE IV PIPERAZINES
First-generation
Cyclizine, hydroxyzine, meclizine
TYPE IV PIPERAZINES
Second-generation
Cetirizine, levocetirizine
TYPE V PIPERIDINES
First-generation
Azatadine, cyproheptadine, ketotifen
TYPE V PIPERIDINES
Second-generation
Fexofenadine, loratadine, desloratadine
TYPE VI PHENOTHIAZINES
First-generation
Methdilazine, promethazine